ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17/01/2024
Voltar para busca
Dado oficial do USPTO
AXCELLA HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
17/01/2024
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
06/06/2016
Data de registro
15/03/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/03/2022
Última transação
15/03/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
05/11/2021
Primeiro uso no comércio
05/11/2021
Código do desenho
4
Tipo de titular
16
Localização do titular
SANTA CLARA, CA
Examinador
MAKHDOOM,SAIMA
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
AXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Axcella Health Inc.
Representantes
Christina M. Licursi, Esq. WOLF GREENFIELD & SACKS PC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Dietary supplements for human and animal use; dietary supplements for restoring health in patients with diseasesdisorders and conditions associated with amino acid dysregulationdisruption of cellular homeostasisprotein energy dysfunctionthe muscular systemthe skeletal systemthe cardiovascular systemthe hematological systemthe respiratory systemthe hepatobiliary systemthe gastrointestinal systemthe endocrine systemthe urinary systemthe reproductive systemthe immune systemthe integumentary systemmusclebonesjointswhole body movement; proteinspolypeptidespeptidesamino acidssmall molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseasesdisorders and conditions associated with amino acid dysregulationdisruption of cellular homeostasisprotein energy dysfunctionthe muscular systemthe skeletal systemthe cardiovascular systemthe hematological systemthe respiratory systemthe hepatobiliary systemthe gastrointestinal systemthe endocrine systemthe urinary systemthe reproductive systemthe immune systemthe integumentary systemmusclebonesjoints; nutraceuticals for treating or restoring health in patients with diseasesdisorders and conditions associated with amino acid dysregulationdisruption of cellular homeostasisprotein energy dysfunctionthe muscular systemthe skeletal systemthe cardiovascular systemthe hematological systemthe respiratory systemthe hepatobiliary systemthe gastrointestinal systemthe endocrine systemthe urinary systemthe reproductive systemthe immune systemthe integumentary systemmusclebonesjoints; dietary and nutritional supplements
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
15/03/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/02/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/02/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/02/2022
IUAF
USE AMENDMENT FILED
28/01/2022
EISU
TEAS STATEMENT OF USE RECEIVED
28/01/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/07/2021
EX2G
SOU EXTENSION 2 GRANTED
27/07/2021
EXT2
SOU EXTENSION 2 FILED
27/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
27/07/2021
NOAC
CORRECTED NOA E-MAILED
23/02/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/02/2021
EX1G
SOU EXTENSION 1 GRANTED
22/02/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
22/02/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
16/02/2021
EXT1
SOU EXTENSION 1 FILED
28/01/2021
DRRR
DIVISIONAL REQUEST RECEIVED
28/01/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
28/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
28/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2020
PUBO
PUBLISHED FOR OPPOSITION
02/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/04/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
28/04/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/11/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/05/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/11/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/05/2018
GNSL
LETTER OF SUSPENSION E-MAILED
07/05/2018
CNSL
SUSPENSION LETTER WRITTEN
07/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/10/2017
GNRT
NON-FINAL ACTION E-MAILED
26/10/2017
CNRT
NON-FINAL ACTION WRITTEN
26/10/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/10/2017
ALIE
ASSIGNED TO LIE
18/10/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/10/2017
EXPI
EX PARTE APPEAL-INSTITUTED
05/10/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/10/2017
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
05/10/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/09/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/09/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/04/2017
GNFR
FINAL REFUSAL E-MAILED
05/04/2017
CNFR
FINAL REFUSAL WRITTEN
05/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/03/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/09/2016
GNRT
NON-FINAL ACTION E-MAILED
16/09/2016
CNRT
NON-FINAL ACTION WRITTEN
16/09/2016
DOCK
ASSIGNED TO EXAMINER
16/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/06/2016
NWAP
NEW APPLICATION ENTERED
09/06/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AXCELLA HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.